Eurizon Capital SGR SpA’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Eurizon Capital SGR SpA's VRTX Position: Q2 2026 in Review
Eurizon Capital SGR SpA increased its Vertex Pharmaceuticals (VRTX) stake by 1.3% in Q2 2026, buying an estimated $476K and bringing the position to 82,582 shares worth $41M. The position accounts for 0.11% of the portfolio, ranked #155.
Eurizon Capital SGR SpA first reported a position in VRTX in Q4 2025 and has held it in 3 quarters since. 1,744 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Eurizon Capital SGR SpA held 82,582 shares of Vertex Pharmaceuticals worth $41M as of Q2 2026.
- Eurizon Capital SGR SpA bought 1,073 Vertex Pharmaceuticals shares in Q2 2026, an estimated $476K.
- Vertex Pharmaceuticals made up 0.11% of Eurizon Capital SGR SpA's portfolio in Q2 2026, its #155 holding.
- Eurizon Capital SGR SpA first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- 1,744 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Eurizon Capital SGR SpA's 13F filing for Q2 2026, filed 29 Jul 2026.